概要
The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships to key regulatory and clinical considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.
Bringing together key stakeholders from the drug/device and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.
Need approval in order to attend?
Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.Check out our 2019 Program!
Why Attend?
プログラム委員会
-
Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada -
Lisa Chartrand Director, Regulatory Strategy and Policy
Hoffmann-La Roche Limited, Canada -
Loretta Del Bosco Director, Regulatory Affairs Quality Assurance Operations
AbbVie Corporation, Canada -
Fiona M Frappier, PhD Senior Policy Analyst
Health Canada, Canada -
Lorella Garofalo, PhD Head of Regulatory Sciences
Pfizer Canada ULC, Canada -
Melissa Hunt, MSc Director
Health Canada, Canada -
Yatika Kohli, PhD, MBA Chief Compliance and Strategy Officer
NoNO Inc, Canada -
Rania Mouchantaf, PhD A/Executive Director, Marketed Pharmaceuticals Bureau, MHPD
Health Canada, Canada -
Kristin Willemsen, MS Vice President, Scientific & Regulatory Affairs
Food, Health & Consumer Products of Canada, Canada
